Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for…
$5.22+4.19%
报价 2026-11-06
市值
$78.2M
EV
$75.9M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -41.8%
$1.90$8.97
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| CPIXCumberland Pharmaceuticals Inc. | $78.2M | +4.2% | -14.9% | 83.4% | – | – | – | |
| RMTIRockwell Medical, Inc. | $31.2M | +1.7% | +4.3% | 17.7% | – | – | 21.2x | |
| ABVCABVC BioPharma, Inc. | $25.9M | -0.2% | +740.5% | 100% | – | – | – | |
| CELUCelularity Inc. | $24.7M | +4.8% | +76.0% | 19.2% | – | – | – | |
| DYAIDyadic International, Inc. | $13.6M | -0.1% | +71.8% | 30.4% | – | – | – | |
| QNTMQuantum BioPharma Ltd. | $13.5M | -0.2% | – | 0% | – | – | – | |
| LTRNLantern Pharma Inc. | $8.5M | +6.7% | – | 0% | – | – | – | |
| CALCCalciMedica, Inc. | $4.3M | +4.6% | -90.4% | 0% | – | – | – | |
| 同行中位数 | – | – | +71.8% | 17.7% | – | – | 21.2x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。